Literature DB >> 4646277

The action of L(-)-dopa on baroreflexes in Parkinsonism.

J L Reid, D B Calne, C F George, S D Vakil.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4646277     DOI: 10.1042/cs0430851

Source DB:  PubMed          Journal:  Clin Sci        ISSN: 0009-9287            Impact factor:   6.124


× No keyword cloud information.
  7 in total

Review 1.  Modeling and imaging cardiac sympathetic neurodegeneration in Parkinson's disease.

Authors:  Valerie Joers; Marina E Emborg
Journal:  Am J Nucl Med Mol Imaging       Date:  2014-03-20

2.  The cardiovascular effects of bromocriptine in Parkinsonism.

Authors:  J K Greenacre; P F Teychenne; A Petrie; D B Calne; P N Leigh; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1976-08       Impact factor: 4.335

Review 3.  Bromocriptine in the treatment of parkinsonism.

Authors:  J D Parkes
Journal:  Drugs       Date:  1979-05       Impact factor: 9.546

4.  Drug metabolism by the gastrointestinal mucosa.

Authors:  C F George
Journal:  Clin Pharmacokinet       Date:  1981 Jul-Aug       Impact factor: 6.447

5.  Bromocriptine in Parkinson's disease: a study of cardiovascular effects.

Authors:  N Quinn; A Illas; F Lhermitte; Y Agid
Journal:  J Neurol Neurosurg Psychiatry       Date:  1981-05       Impact factor: 10.154

6.  Effects of orthostatic hypotension on cognition in Parkinson disease.

Authors:  Justin Centi; Roy Freeman; Christopher H Gibbons; Sandy Neargarder; Alexander O Canova; Alice Cronin-Golomb
Journal:  Neurology       Date:  2016-11-30       Impact factor: 9.910

7.  Autonomic Function Impairment and Brain Perfusion Deficit in Parkinson's Disease.

Authors:  Wei-Che Lin; Pei-Chin Chen; Chih-Cheng Huang; Nai-Wen Tsai; Hsiu-Ling Chen; Hung-Chen Wang; Kun-Hsien Chou; Meng-Hsiang Chen; Yi-Wen Chen; Cheng-Hsien Lu
Journal:  Front Neurol       Date:  2017-06-08       Impact factor: 4.003

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.